All Type of News
Most imported ETC product, ‘Baraclude’
Which do you think is the ETC drug imported the most?
According to the analysis result of the 2015’s ETC drugs exported the most in 2015, published by the Korea Pharmaceutical Traders Association, the last year’s mos...
Ceiling price of domestically-developed new drugs will be recognized
Domestically-developed new drugs were confirmed to be recognized at the ceiling price of their generics.
The Ministry of Health and Welfare(Minister Jin-yup Jung) and the Health Insurance Review & Assessment Service(...
Janssen’s HIV treatment, ‘Presecobics’ applied by health insurance from March
Janssen Korea(CEO Ok-yeon Kim) announced ‘Presecobics(generic name: darunavir 800mg, cobicistat 150mg),’ a complex human immunodeficiency virus(HIV) treatment, will be applied by the National Health Insurance from the...
Original products’ claims have enlarged after the drug price cuts
The drug price cuts on April 2012 was enforced with changes that are important in the drug pricing system.
It had had contained abolition of the stepped drug pricing system which set drug prices depending on generic...
Will rotavirus vaccines be included in NIP?
The government is currently considering to include rotavirus vaccines in the National Immunization Program.
Director Jung-ik Hong at the Vaccination Management Division, Korea Centers for Disease Control and Preventi...
Which took the top among imported drugs?
Which do you think was the most imported OTC drug into Korea last year?
According to the analysis result of the 2015’s OTC drug imports revealed by the Korea Pharmaceutical Traders Association, pharmaceutical product...
Win-win strategy of noticeable domestic-multinational companies’ co-marketing
This year, again, domestic pharmaceutical companies have been attracted to co-marketing of multinational pharmaceutical companies’ products. Although a part of the industry has still criticized the phenomenon as ‘subo...
Pharmaceutical industry’s personnel demands increases 2.5% up to 160 thousand by 2024
The pharmaceutical industry’s demands for human resources were expected to increase 2.5% up annually to 160 thousand in 2024.
The Korea Health Industry Development Institute unveiled an observation of the pharmaceut...
While Belviq leads, generic Xenical outnumbers the original
The impact of ‘Belviq’ was significant in the obesity treatment market. Ildong Pharmaceuticals’ Belviq(lorcaserin), which was first launched on March last year, recorded approximately KRW 14 billion sales in 10 months...
Revolade earns insurance benefit from 1st
The drug benefit standards for 4 new drugs, such as a thrombocytopenia treatment, Revolade, will open from the 1st of the next month. On the same day, the benefit standards for painkillers in the combination with Lyri...
